Point72 Asset Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
|
|||||
|
2025
Q1 | $2.76M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $788K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $6.74M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.45M | Sell |
|
|||||
|
2022
Q4 | $7.6M | Sell |
|
|||||
|
2022
Q3 | $5.88M | Sell |
|
|||||
|
2022
Q2 | $9.14M | Buy |
|
|||||
|
2022
Q1 | $5.55M | Sell |
|
|||||
|
2021
Q4 | $9.35M | Sell |
|
|||||
|
2021
Q3 | $10M | Buy |
|
|||||
|
2021
Q2 | $7.23M | Hold |
|
|||||
|
2021
Q1 | $6.61M | Sell |
|
|||||
|
2020
Q4 | $7.01M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $48K | Hold |
|
|||||
|
2019
Q3 | $73K | Hold |
|
|||||
|
2019
Q2 | $204K | Sell |
|
|||||
|
2019
Q1 | $320K | Hold |
|
|||||
|
2018
Q4 | $348K | Sell |
|
|||||
|
2018
Q3 | $2.01M | Buy |
|